Immuneering Corporation (IMRX) PT Lowered to $12; Piper Sandler: 'We Remain Buyers'
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel lowered the price target on Immuneering Corporation (NASDAQ: IMRX) to $12.00 (from $13.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
